Quidel Corp

$128.83 0.00% ($0.00)
  • 1D
  • 1W
  • 1M
  • 1Y
  • 5Y
  • YTD

Get ready to invest

Join the waitlist

About Quidel Corp

Quidel Corp. is engaged in the development, manufacturing and marketing of diagnostic testing solutions. These diagnostic testing solutions are separated into four product categories: rapid immunoassays, cardiac immunoassay, specialized diagnostic solutions and molecular diagnostic solutions. It sells its products directly to end users and distributors, in each case, for professional use in physician offices, hospitals, clinical laboratories, reference laboratories, universities, retail clinics, pharmacies and wellness screening centers. Its diagnostic solutions aid in the detection and diagnosis of many diseases and medical conditions, including infectious diseases, cardiovascular diseases and conditions, women’s health, gastrointestinal diseases, autoimmune diseases, bone health and thyroid diseases. The Company provides diagnostic testing solutions under various brand names, including Quidel, QuickVue, QuickVue+, D3 FastPoint, Super E-Mix, ELVIS, Sofia, Amplivue, Lyra and Thyretain.

Stock Analysis

last close $125.98
1-mo return -10.7%
3-mo return -38.4%
avg daily vol. 726.41T
52-week high 306.72
52-week low 106.13
market cap. $5.2B
forward pe 4.8
annual div. -
roe 85.6%
ltg forecast -
dividend yield -
annual rev. $1.7B
inst own. 88.2%

Join the waitlist for early access and a chance to earn $50 in free stock

Join the waitlist